2004 May;137(5):503-6
Ilic, S., Drmic, D., Franjic, S., Kolenc, D., Coric, M., Brcic, L., Klicek, R., Radic, B., Sever, M., Djuzel, V., Filipovic, M., Djakovic, Z., Stambolija, V., Blagaic, A
It is supplied here as a lyophilised research chemical for in-vitro laboratory use only
[ Links ] 50
You may be an ideal candidate if you: Experience persistent fatigue or low energy Have unexplained weight gain or difficulty losing weight Suffer from mood swings, anxiety, or depression Experience hot flashes or night sweats Have difficulty sleeping or staying asleep Notice decreased libido or sexual dysfunction Experience brain fog or memory issues Are going through perimenopause, menopause, or andropause Hormone Therapy May Require Special Consideration If You: Are currently pregnant or breastfeeding Have a history of hormone-sensitive cancers Have active blood clots or clotting disorders Have severe liver disease Have unexplained vaginal bleeding Have a history of stroke or heart attack Take certain medications that may interact During your consultation, our providers will review your medical history and current medications to ensure hormone therapy is safe and appropriate for you

CJC-1295 provides sustained GH/IGF-1 elevation, while Ipamorelin creates rapid GH pulses, closely mimicking natural hormone rhythms and potentially reducing off-target side effects.